All Stories

  1. Decrease in Cell Viability of Breast Cancer Cells by a Di-Hydroxylated Derivative of N-(2-hydroxyphenyl)-2-Propylpentanamide

    Article • Anti-Cancer Agents in Medicinal Chemistry, May 2022, Bentham Science Publishers

    Jose Correa Basurto

  2. Apoptotic Effects of N-(2-Hydroxyphenyl)-2-Propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2021, Bentham Science Publishers

    Jose Correa Basurto

  3. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes

    Article • Anti-Cancer Agents in Medicinal Chemistry, October 2020, Bentham Science Publishers

    M Jonathan Fragoso Vázquez, PhD Jose Ruben Garcia Sanchez, Jose Correa Basurto

  4. Molecular dynamics simulations reveal structural differences among wild-type NPC1 protein and its mutant forms

    Article • Journal of Biomolecular Structure and Dynamics, September 2019, Taylor & Francis

    Jose Correa Basurto

  5. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2019, Bentham Science Publishers

    PhD Jose Ruben Garcia Sanchez, M Jonathan Fragoso Vázquez, Jose Correa Basurto

  6. Docking analysis provide structural insights to design novel ligands that target PKM2 and HDC8 with potential use for cancer therapy

    Article • Molecular Simulation, February 2019, Taylor & Francis

    Jose Correa Basurto, Edgar Abarca-Rojano

  7. Studying the collective motions of the adenosine A2A receptor as a result of ligand binding using principal component analysis

    Article • Journal of Biomolecular Structure and Dynamics, January 2019, Taylor & Francis

    Jose Correa Basurto, Jorge Rosas-Trigueros

  8. Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand

    Article • Anti-Cancer Agents in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Jose Correa Basurto, M Jonathan Fragoso Vázquez, Edgar Abarca-Rojano

  9. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells

    Article • Anti-Cancer Agents in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Jose Correa Basurto, PhD Jose Ruben Garcia Sanchez, M Jonathan Fragoso Vázquez

  10. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6

    Article • Journal of Biomolecular Structure and Dynamics, December 2018, Taylor & Francis

    Jose Correa Basurto, PhD Yudibeth Sixto-López

  11. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking

    Article • Journal of Biomolecular Structure and Dynamics, March 2018, Taylor & Francis

    Jose Correa Basurto

  12. Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells

    Article • Anti-Cancer Agents in Medicinal Chemistry, October 2017, Bentham Science Publishers

    Jose Correa Basurto

  13. QSAR, DFT and molecular modeling studies of peptides from HIV-1 to describe their recognition properties by MHC-I

    Article • Journal of Biomolecular Structure and Dynamics, August 2017, Taylor & Francis

    Jose Correa Basurto

  14. Docking and QSAR Studies of Aryl-valproic Acid Derivatives to Identify Antiproliferative Agents Targeting the HDAC8

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2017, Bentham Science Publishers

    Jose Correa Basurto